Form 4: Twist Bioscience Exec Sells Shares for Tax Cover

Twist Bioscience's Chief Legal Officer, Dennis Cho, sold 757 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp (TWST), reported a transaction.
• On November 21, 2025, Cho disposed of 757 shares of common stock at a price of $26.5035 per share.
• This sale was mandated by the issuer's equity incentive plans to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).
• The transaction was a 'sell to cover' and does not represent a discretionary trade by Mr. Cho.
• Following this transaction, Dennis Cho beneficially owns 145,402 shares of Twist Bioscience common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction for tax purposes, not indicative of management's view on the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to compensation and tax obligations, which is common across all industries for executives receiving equity-based compensation. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.

Key Dates

Recommendation

This Form 4 filing details a 'sell to cover' transaction by an executive, which is a non-discretionary sale to satisfy tax obligations upon RSU vesting. Such transactions are routine and do not typically reflect the insider's sentiment about the company's future performance or stock price. Therefore, this filing alone does not warrant a change in investment recommendation; a 'hold' stance is maintained based on existing fundamental analysis.

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Tax Withholding, RSU Vesting, Dennis Cho